Harris, Claire L.
Funding for this research was provided by:
Newcastle University
Article History
Received: 28 July 2017
Accepted: 19 September 2017
First Online: 6 October 2017
Compliance with ethical standards
:
: CLH was an employee of GlaxoSmithKline (2013–2016) and has received consultancy income from GlaxoSmithKline, Gemini Therapeutics and Gyroscope Therapeutics; all monies received have been donated to the University for research.